Tempsens Instruments (India) IPO Day 4: GMP ₹285 (+₹15)

Welcome back, investors! It’s Day 4 of the Tempsens Instruments (India) IPO, and we’re diving deep into the latest subscription numbers and Grey Market Premium (GMP) movements. The IPO, priced at ₹300 per share, is scheduled to close on August 24, 2026, and the anticipation is building. Let’s see how things are shaping up as we approach the final day.

Subscription Status

As of Day 4, the subscription figures for Tempsens Instruments IPO stand at a rather intriguing 0x across all categories – Retail, High Net-worth Individuals (HNIs or NIIs), and Qualified Institutional Buyers (QIBs). This means that, officially, not a single share has been subscribed for yet. Now, this might sound concerning at first glance, but it’s not entirely unusual for mainboard IPOs, especially those with a slightly longer subscription window. Often, the bulk of the subscriptions pour in on the final day. However, it’s also a point to watch closely. The lack of early traction could indicate a few things: perhaps investors are waiting for the last-minute rush, or maybe they’re still evaluating the company’s fundamentals. The QIB category, in particular, is a significant indicator of institutional confidence. Their silence so far is something to monitor; a strong showing from them typically bodes well for the IPO’s success. Similarly, NIIs often jump in towards the end. For retail investors, this means there’s still plenty of opportunity to get in, but the overall sentiment will likely be clearer by tomorrow morning.

GMP Update

Interestingly, the Grey Market Premium (GMP) for Tempsens Instruments IPO is showing a positive trend. The current GMP is at ₹285, a notable increase of ₹15 from yesterday’s ₹270. This upward movement in GMP is a strong signal of market sentiment. It suggests that demand for the stock in the unlisted market is strengthening. If this GMP holds, it translates to a potential listing price of approximately ₹585 per share (Issue Price ₹300 + GMP ₹285). This is a significant premium and certainly catches the eye. The increase in GMP, despite the subdued subscription numbers so far, indicates that market participants are optimistic about the company’s future prospects and its potential on listing day. It’s a good sign for potential applicants, showing that there’s a healthy appetite for the stock even before it officially lists.

Should You Apply?

So, the big question: should you be applying for the Tempsens Instruments IPO? It’s a classic case of balancing the data. On one hand, the subscription numbers are currently non-existent, which might give some pause. However, this is often the calm before the storm, especially with mainboard issues. On the other hand, the GMP is looking robust and has shown a healthy upward tick. This suggests strong grey market demand, potentially leading to a profitable listing. Remember, GMP is not a foolproof indicator, but it’s a valuable sentiment gauge. The lot size is 50 shares, so keep that in mind for your investment calculations. As per SEBI advisor guidelines, it’s always prudent to do your own due diligence. Assess the company’s financials, its business model, and its competitive landscape. If you’re comfortable with the risk profile and the potential for a good listing gain indicated by the GMP, and you believe in the long-term story of Tempsens Instruments, then applying could be a wise move. However, if you prefer to see concrete subscription numbers before committing, waiting until the final hours might be your strategy. The bottom line is, the market seems to like Tempsens Instruments, even if the official subscription channels haven’t fully reflected it yet. You can View Full Tempsens Instruments (India) IPO Details for more in-depth analysis.